Two Sigma Securities’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Two Sigma Securities’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-25,296	Closed	-$7K	–	3483
2022 Q3	$7K	Buy	+25,296	New	+$11K	﹤0.01%	2457
2022 Q1	–	Sell	-15,282	Closed	-$29K	–	2670
2021 Q4	$29K	Buy	+15,282	New	+$36.6K	﹤0.01%	1367
2018 Q1	–	Sell	-12,927	Closed	-$47K	–	3046
2017 Q4	$47K	Buy	+12,927	New	+$48.8K	﹤0.01%	1539

Two Sigma Securities's AGTC Position: Q4 2022 in Review

Two Sigma Securities sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 25,296 shares — an estimated $7K sold.

Two Sigma Securities first reported a position in AGTC in Q4 2017 and held it in 3 quarters. The position peaked at $47K in Q4 2017. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.

Two Sigma Securities reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
Two Sigma Securities sold 25,296 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $7K.
Two Sigma Securities first reported a position in Applied Genetic Technologies Corporation in Q4 2017 and held it in 3 quarters.
Two Sigma Securities's Applied Genetic Technologies Corporation position peaked at $47K in Q4 2017.
0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.

Based on Two Sigma Securities's 13F filing for Q4 2022, filed 14 Feb 2023.